Product Information
ERYTHROMYCIN ES 400 MG TAB is a generic product labeled by Azurity Pharmaceuticals Inc., priced at $11.7351 per EA under NDC 24338011003. Its NADAC has been published 74 times since Apr 17, 2024.
Strength
400 mg/1
Manufacturer
Azurity Pharmaceuticals Inc.NDC
24338011003
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
9/18/2024
Active Ingredients
ERYTHROMYCIN ETHYLSUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA061904On Market Since
10/3/2011
Pharmacological Classes
Price Statistics
The NADAC for ERYTHROMYCIN ES 400 MG TAB has been published 74 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.7351 per EA |
|---|---|
| All-time high | $11.7351 (Sep 10, 2025) |
| All-time low | $11.6852 (Apr 17, 2024) |
| 52-week high | $11.7351 |
| 52-week low | $11.7351 |
| Median price | $11.7351 |
| Average price | $11.7289 |
| Largest weekly change | +0.2% (Jul 17, 2024) |
| Weeks tracked | 74 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Erythromycin Ethylsuccinate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN ES 400 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN ES 400 MG TAB, manufactured by Azurity Pharmaceuticals Inc., is $11.7351 per EA (NDC 24338011003), effective Sep 10, 2025.
How has the price of ERYTHROMYCIN ES 400 MG TAB changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN ES 400 MG TAB has held within roughly two percent of its current level. It has been tracked across 74 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN ES 400 MG TAB?
Since Apr 17, 2024, the NADAC for ERYTHROMYCIN ES 400 MG TAB has ranged from a low of $11.6852 (Apr 17, 2024) to a high of $11.7351 (Sep 10, 2025), with a median of $11.7351 per EA.
Are there cheaper alternatives to ERYTHROMYCIN ES 400 MG TAB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ERYTHROMYCIN ES 400 MG TAB, so no direct lower-cost alternative is listed.
Who manufactures ERYTHROMYCIN ES 400 MG TAB?
ERYTHROMYCIN ES 400 MG TAB (NDC 24338011003) is labeled by Azurity Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification